Navigating FDA Compliance: A Guide for Life Sciences Startups with Troy Fugate
Unable to add items
Add to basket failed.
Add to wishlist failed.
Failed to remove from Wish List.
Adding to library failed
Unable to follow podcast
Unable to unfollow podcast
-
Narrated by:
-
By:
Is your startup ready for FDA scrutiny — or are you building on a shaky foundation?
In this episode of From Lab to Patient, Garage to Market, Phil Crowley sits down with Troy Fugate, founder of Compliance Insight and a regulatory affairs veteran with over 30 years of experience in the life sciences industry. Troy breaks down what early-stage biotech and medical device companies get wrong about FDA compliance, why your CDMO relationship can make or break your product, and how to build a quality culture that regulators actually trust.
In this episode:
- Why compliance has to be built in from day one — not bolted on later
- What to look for (and watch out for) when choosing a CDMO partner
- The difference between phase-appropriate GMP and cutting corners
- How AI is starting to reshape regulatory strategy
Troy also shares practical advice for founders who are navigating the regulatory landscape for the first time — and what it really takes to earn FDA trust.
🔗 Learn more about Troy Fugate and Compliance Insight: compliance-insight.com
📧 Reach Troy directly: tfugate@compliance-insight.com
📚 Get Phil's book Avoid Startup Failure! on Amazon